BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9685183)

  • 1. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes.
    Sakitani K; Nishizawa M; Inoue K; Masu Y; Okumura T; Ito S
    Genes Cells; 1998 May; 3(5):321-30. PubMed ID: 9685183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
    Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
    J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
    Kolyada AY; Madias NE
    Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
    Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
    J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes.
    Oda M; Sakitani K; Kaibori M; Inoue T; Kamiyama Y; Okumura T
    J Biol Chem; 2000 Feb; 275(6):4369-73. PubMed ID: 10660607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
    Yu Z; Zhang W; Kone BC
    Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells.
    Teng X; Zhang H; Snead C; Catravas JD
    Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene.
    Taylor BS; de Vera ME; Ganster RW; Wang Q; Shapiro RA; Morris SM; Billiar TR; Geller DA
    J Biol Chem; 1998 Jun; 273(24):15148-56. PubMed ID: 9614127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes.
    Kinugawa K; Shimizu T; Yao A; Kohmoto O; Serizawa T; Takahashi T
    Circ Res; 1997 Dec; 81(6):911-21. PubMed ID: 9400371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
    Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA
    J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages.
    Gupta AK; Diaz RA; Higham S; Kone BC
    Kidney Int; 2000 Jun; 57(6):2239-48. PubMed ID: 10844594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for C/EBPbeta binding to the AABS promoter response element in the human iNOS gene.
    Guo Z; Shao L; Feng X; Reid K; Marderstein E; Nakao A; Geller DA
    FASEB J; 2003 Sep; 17(12):1718-20. PubMed ID: 12958187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter.
    Wei J; Guo H; Gao C; Kuo PC
    Biochem J; 2004 Feb; 377(Pt 3):809-18. PubMed ID: 14599292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation.
    de Lucas S; Bartolomé J; Amaro MJ; Carreño V
    Antiviral Res; 2003 Oct; 60(2):117-24. PubMed ID: 14638407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation.
    Majano P; Lara-Pezzi E; López-Cabrera M; Apolinario A; Moreno-Otero R; García-Monzón C
    Hepatology; 2001 Dec; 34(6):1218-24. PubMed ID: 11732012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.
    Takahashi M; Mutoh M; Shoji Y; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
    Oncogene; 2003 Oct; 22(48):7667-76. PubMed ID: 14576830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells.
    Teng X; Zhang H; Snead C; Catravas JD
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C144-52. PubMed ID: 11742807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
    Agrawal A; Cha-Molstad H; Samols D; Kushner I
    J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.